Transformative Technologies for Early Cancer Detection

Who We Are

Unique Solutions for Truly Personalized Medicine

Innovative Diagnostic Solutions for Patients and Physicians

Improving patient outcomes through early cancer detection
Our mission at Naveris is to develop highly sensitive blood tests for early cancer detection
Core Technologies

Circulating Tumor DNA

Ultra sensitive and quantitative method for non-invasive cancer detection.

News & Publications

–Researchers identify traits linked to better outcomes in HPV-linked head and neck cancer 

–HPV blood test shows promise for tracking head and neck cancer after treatment

–Naveris Congratulates Scientific Advisors Bhisham Chera and Gaorav Gupta on Presentation of Clinical Data at the 2018 ASTRO Annual Meeting

 

Follow us on: